IRIS
SALVATORE, Giuliana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.449
EU - Europa 3.976
AS - Asia 1.060
SA - Sud America 171
Continente sconosciuto - Info sul continente non disponibili 20
AF - Africa 14
OC - Oceania 4
Totale 11.694
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.433
RU - Federazione Russa 1.549
UA - Ucraina 670
IT - Italia 385
VN - Vietnam 378
SG - Singapore 356
SE - Svezia 344
GB - Regno Unito 294
DE - Germania 288
CN - Cina 246
FR - Francia 165
BR - Brasile 152
FI - Finlandia 92
NL - Olanda 79
HK - Hong Kong 20
EU - Europa 19
PL - Polonia 18
AT - Austria 17
BE - Belgio 15
IE - Irlanda 13
CZ - Repubblica Ceca 12
CA - Canada 9
IN - India 9
TR - Turchia 9
AR - Argentina 6
PT - Portogallo 5
BG - Bulgaria 4
IL - Israele 4
JP - Giappone 4
KR - Corea 4
MX - Messico 4
PK - Pakistan 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
EC - Ecuador 3
MA - Marocco 3
PE - Perù 3
RO - Romania 3
UZ - Uzbekistan 3
AM - Armenia 2
AU - Australia 2
CH - Svizzera 2
CO - Colombia 2
DK - Danimarca 2
EG - Egitto 2
ES - Italia 2
GR - Grecia 2
HU - Ungheria 2
LK - Sri Lanka 2
LV - Lettonia 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
RS - Serbia 2
SA - Arabia Saudita 2
SN - Senegal 2
VE - Venezuela 2
AL - Albania 1
BD - Bangladesh 1
BT - Bhutan 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
MC - Monaco 1
MK - Macedonia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.694
Salva come PNG Salva come JPEG
Città #
Fairfield 965
Woodbridge 707
Houston 587
Chandler 454
Ann Arbor 444
Ashburn 399
Seattle 395
Dong Ket 377
Wilmington 377
Cambridge 327
Moscow 272
Nyköping 220
Dearborn 207
Singapore 207
The Dalles 195
Jacksonville 177
Boardman 157
Southend 146
Naples 103
Napoli 76
Beijing 72
Princeton 70
Lawrence 64
Groningen 63
Grafing 59
Yubileyny 58
New York 52
Ogden 52
Munich 42
Shanghai 40
San Diego 36
Helsinki 33
Düsseldorf 26
Des Moines 24
Formia 23
Milan 21
Los Angeles 20
Hong Kong 19
Jinan 17
London 17
Norwalk 17
Lauterbourg 15
Brussels 14
Hefei 14
Kunming 13
Boydton 12
Auburn Hills 11
Dublin 11
Frankfurt am Main 11
Kraków 11
São Paulo 11
Dallas 10
Nanjing 10
Vienna 10
Redmond 9
Afragola 8
Bremen 8
Edinburgh 8
Nocera Inferiore 8
Redwood City 8
Amsterdam 7
Brno 7
Rome 7
Atlanta 6
Shenyang 6
Turku 6
Casoria 5
Guangzhou 5
Kilburn 5
Nanchang 5
Nocera Superiore 5
Nuremberg 5
St Louis 5
Stockholm 5
Bexley 4
Hangzhou 4
Matawan 4
Portsmouth 4
Rio de Janeiro 4
Santa Clara 4
Shenzhen 4
Tokyo 4
Zhengzhou 4
Altavilla Irpina 3
Baku 3
Chongqing 3
Costa Mesa 3
Fuzhou 3
Giugliano in Campania 3
Jundiaí 3
Kocaeli 3
Lisbon 3
Nova Iguaçu 3
Olomouc 3
Pescara 3
Recife 3
Roubaix 3
Sofia 3
São Bernardo do Campo 3
Tashkent 3
Totale 7.985
Salva come PNG Salva come JPEG
Nome #
Extracellular superoxide dismutase is a thyroid differentiation marker down-regulated in cancer 320
TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells 280
Junctional adhesion molecule-A is down-regulated in anaplastic thyroid carcinomas and reduces cancer cell aggressiveness by modulating p53 and GSK3 α/β pathways 247
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma 246
Unveiling the miRNAs responsive to physical activity/exercise training in cancer: A systematic review 244
Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer 242
Long-term recreational football training and health in aging 236
Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells 218
Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. 217
Anaplastic Thyroid Carcinoma: Molecular Tools for Diagnosis and Therapy 215
Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma Cells 213
Identification of polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma 212
RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma 207
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles 202
BAY 43-9006 inhibition of oncogenic RET mutants. 200
Preclinical Imaging for the Study of Mouse Models of Thyroid Cancer 197
miR-650 promotes motility of anaplastic thyroid cancer cells by targeting PPP2CA 197
The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma 195
Analysis of BRAF Point Mutation and RET/PTC Rearrangement Refines the Fine-Needle Aspiration Diagnosis of Papillary Thyroid Carcinoma 191
A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts. 191
BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma 188
YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes 188
Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1) 184
High-Frequency Ultrasound-Guided Injection for the Generation of a Novel Orthotopic Mouse Model of Human Thyroid Carcinoma 184
BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas 182
Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins 181
Identification of targets of twist1 transcription factor in thyroid cancer cells. 180
Glial cell line-derived neutrotrophic factor and neurturin can act as paracrine growth factors stimulating DNA synthesis of Ret-expressing spermatogonia 178
Different mutations of the RET gene cause different human tumoral diseases 178
Receptor tyrosine kinase inhibitors in thyroid cancer 175
BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas 174
Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase 171
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma 170
DNA immunization followed by a single boost with cells: a protein-free immunization protocol for production of monoclonal antibodies against the native form of membrane proteins 168
Dissecting the molecular pathways involved in the effects of physical activity on breast cancers cells: A narrative review 168
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells 164
Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness 161
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma. 161
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential 159
PATE, a gene expressed in prostate cancer, normal prostate, and testis, identified by a functional genomic approach 156
Identification of a novel subtype of H4-RET rearrangement in a thyroid papillary carcinoma and lymph node metastasis 156
Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins 154
Morphological ultrasound microimaging of thyroid in living mice 154
MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer 152
High Frequency Ultrasound for the development of an Orthotopic mouse model of Human Follicular Thyroid Carcinoma 148
Novel candidate genes of thyroid tumourigenesis identified in Trk-T1 transgenic mice. 148
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease 146
Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas 143
TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype 142
Presence of BRAF V600E in Very Early Stages of Papillary Thyroid Carcinoma 142
Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas 136
Mitogenic effects of the up-regulation of MiniChromosome Maintenance proteins (MCM) in anaplastic thyroid carcinoma 135
Molecular profile of hyalinizing trabecular tumors of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations 135
Pros and cons of cellular studies in developing new drugs for thyroid cancers 133
Monitoring training in non-professional soccer players by coupling SSGs and GPS technology: effects of pitch size and players role 132
Molecular biology of the MEN2 gene 131
miR-622 Is a Novel Potential Biomarker of Breast Carcinoma and Impairs Motility of Breast Cancer Cells Through Targeting NUAK1 Kinase 127
Frequent mutation of PIK3CA in Anaplastic Thyroid Cancer 124
Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display 122
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype 119
Adiponectin and leptin exert antagonizing effects on proliferation and motility of papillary thyroid cancer cell lines 116
Regular football training down-regulates miR-1303 muscle expression in veterans 112
High prevalence of RET/PTC rearrangements in Ukrainian and Belarussia post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant 108
Effects of Annurca Flesh Apple Polyphenols in Human Thyroid Cancer Cell Lines 103
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes 98
The TUSC2 Tumour Suppressor Inhibits the Malignant Phenotype of Human Thyroid Cancer Cells via SMAC/DIABLO Protein 97
Evolution of intra-tumoral heterogeneity across different pathological stages in papillary thyroid carcinoma 95
miR-331-5p Affects Motility of Thyroid Cancer Cell Lines and Regulates BID Expression 91
Preclinical Imaging Evaluation of miRNAs' Delivery and Effects in Breast Cancer Mouse Models: A Systematic Review 85
The lncRNA TEX41 is upregulated in pediatric B-Cells Acute Lymphoblastic Leukemia and it is necessary for leukemic cell growth 70
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 60
Exercise’s impact on lung cancer molecular mechanisms: a current overview 53
Insight into the Role of the miR-584 Family in Human Cancers 51
Association of radiomic features with genomic signatures in thyroid cancer: a systematic review. 40
Novel Biological Strategies for Melanoma Therapy: A Focus on lncRNAs and Their Targeting 12
Aberrant Expression of Non-Coding RNAs in Pediatric T Acute Lymphoblastic Leukemia and Their Potential Application as Biomarkers 8
Nanogel-Mediated Delivery of Doxorubicin and Curcumin in Thyroid Cancer Cells 6
Totale 11.924
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.523
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.523
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202043 0 0 0 0 0 0 0 0 0 0 0 43
2020/20211.740 104 140 173 123 147 85 148 51 74 154 50 491
2021/2022783 53 140 26 199 16 24 108 53 71 41 47 5
2022/20231.485 144 91 140 172 229 216 56 161 159 44 55 18
2023/2024390 29 29 34 23 11 48 19 14 79 23 26 55
2024/20252.923 60 230 36 60 34 293 624 987 148 114 306 31
Totale 11.924